Medtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.
Follow MDT
Medtronic PLC (MDT) P/S ratio
As of 16 October 2026, Medtronic PLC (MDT) trades at a P/S ratio of 3.2×. Over the past ten years it has ranged from 2.6× (June 2026) to 6.3× (April 2021); the current reading is higher than 9% of that period. That is above the Medical Devices industry median of 2.3× and below the Healthcare sector median of 3.4×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2026 | 2.9× | (12.16%) |
| FY2025 | 3.2× | (1.29%) |
| FY2024 | 3.3× | (14.76%) |
| FY2023 | 3.9× | (11.63%) |
| FY2022 | 4.4× | (25.26%) |
| FY2021 | 5.8× | 29.14% |
| FY2020 | 4.5× | 15.69% |
| FY2019 | 3.9× | 7.82% |
| FY2018 | 3.6× | (6.62%) |
| FY2017 | 3.9× | 0.19% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jul 2026 | 2.9× | 1.99% |
| Apr 2026 | 2.9× | (23.12%) |
| Jan 2026 | 3.7× | 10.98% |
| Oct 2025 | 3.3× | (1.07%) |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| PHG Koninklijke Philips N.V. compare | 1.2× |
| GEHC GE HealthCare Technologies Inc. compare | 1.5× |
| BSX Boston Scientific Corporation compare | 3.1× |
| MDT Medtronic PLC | 3.2× |
| STE STERIS plc compare | 3.6× |
| ABT Abbott Laboratories compare | 3.9× |
| SYK Stryker Corporation compare | 4.4× |
| DXCM DexCom, Inc. compare | 6.6× |
| EW Edwards Lifesciences Corporation compare | 7.7× |
| Medical Devices industry median | 2.3× |
| Healthcare sector median | 3.4× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on MDT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement